Tremblant Capital Group »

Alnylam Pharmaceuticals shares owned by Tremblant Capital Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Tremblant Capital Group from 13F filings

Historical chart of Tremblant Capital Group investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Tremblant Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Tremblant Capital Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $31M 95k 330.87
2025-12-31 $44M 110k 397.65